OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Chinese Clinical Oncology (2020) Vol. 10, Iss. 1, pp. 10-10
Open Access | Times Cited: 12
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Chinese Clinical Oncology (2020) Vol. 10, Iss. 1, pp. 10-10
Open Access | Times Cited: 12
Showing 12 citing articles:
Diarylureas as Antitumor Agents
Alessia Catalano, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Applied Sciences (2021) Vol. 11, Iss. 1, pp. 374-374
Open Access | Times Cited: 41
Alessia Catalano, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Applied Sciences (2021) Vol. 11, Iss. 1, pp. 374-374
Open Access | Times Cited: 41
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination
Mengqi Zhu, Mengna Wu, Saiyan Bian, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Mengqi Zhu, Mengna Wu, Saiyan Bian, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR ‐496/programmed cell death ligand 1 axis in an m6A ‐dependent manner
Furong Yu, Peifei Fang, Yonghong Fang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3721-3733
Closed Access | Times Cited: 5
Furong Yu, Peifei Fang, Yonghong Fang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3721-3733
Closed Access | Times Cited: 5
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394
Shukui Qin, Weijia Fang, Zhenggang Ren, et al.
Liver Cancer (2024) Vol. 13, Iss. 4, pp. 389-400
Open Access | Times Cited: 4
Shukui Qin, Weijia Fang, Zhenggang Ren, et al.
Liver Cancer (2024) Vol. 13, Iss. 4, pp. 389-400
Open Access | Times Cited: 4
HBO1 overexpression is important for hepatocellular carcinoma cell growth
Wenhui Zhong, Heping Liu, Li Deng, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 24
Wenhui Zhong, Heping Liu, Li Deng, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 24
Preparation and Evaluation of Hepatoma-Targeting Glycyrrhetinic Acid Composite Micelles Loaded with Curcumin
Xueli Guo, Zhongyan Liu, Lina Wu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 448-448
Open Access
Xueli Guo, Zhongyan Liu, Lina Wu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 448-448
Open Access
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14117-14117
Open Access | Times Cited: 13
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14117-14117
Open Access | Times Cited: 13
Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3
Mengqi Zhu, Jianping Zhang, Saiyan Bian, et al.
Biological Procedures Online (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Mengqi Zhu, Jianping Zhang, Saiyan Bian, et al.
Biological Procedures Online (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 10
In Vitro Cell Density Determines the Sensitivity of Hepatocarcinoma Cells to Ascorbate
Hsiu‐Lung Fan, Shuting Liu, Yung‐Lung Chang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Hsiu‐Lung Fan, Shuting Liu, Yung‐Lung Chang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients
Qi Huo, Junjie Hu, Binfen Hou, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 4
Qi Huo, Junjie Hu, Binfen Hou, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 4
Terapias sistémicas en carcinoma hepatocelular: secuencia de tratamientos
Juan Ignacio Marín
Hepatología (2022), pp. 57-71
Open Access
Juan Ignacio Marín
Hepatología (2022), pp. 57-71
Open Access
Synthesis, Anticancer Evaluation and Molecular Docking Studies of Isonicotinamide and Diaryl Urea Hybrid Motifs
Vanita Marvaniya, Hirak V. Joshi, Ujashkumar Shah, et al.
Asian Journal of Organic & Medicinal Chemistry (2022) Vol. 7, Iss. 2, pp. 179-186
Closed Access
Vanita Marvaniya, Hirak V. Joshi, Ujashkumar Shah, et al.
Asian Journal of Organic & Medicinal Chemistry (2022) Vol. 7, Iss. 2, pp. 179-186
Closed Access
